Cosmetic preparation with ionic UV-A filter and 2,4,6-tris-(biphenyl)-1,3,5-triazine

Abstract

Cosmetic preparation containing a) 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt), b) 2,4,6-Tris-(biphenyl)-1,3,5-triazine.

Description

[0001] The present invention relates to a cosmetic preparation with ionic UV-A filter and 2,4,6-tris-(biphenyl)-1,3,5-triazine.

[0002] The trend away from a refined pallor toward "healthy, athletically tanned skin" has been unbroken for years. To achieve this, people expose their skin to sunlight, as this triggers pigment formation in the form of melanin. However, the ultraviolet radiation from sunlight also has a damaging effect on the skin. In addition to acute damage (sunburn), long-term damage such as an increased risk of skin cancer occurs with excessive exposure to light in the UVB range (wavelength: 280-320 nm). Excessive exposure to UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This causes numerous phototoxic and photoallergic reactions and results in premature skin aging.

[0003] To protect the skin, a number of sunscreen filter substances have been developed that can be used in cosmetic preparations. These UVA and UVB filters are summarized in most industrialized countries in the form of positive lists, such as Annex 7 of the Cosmetics Regulation.

[0004] However, the large number of commercially available sunscreens should not obscure the fact that these state-of-the-art preparations have a number of disadvantages.

[0005] A particular challenge is the balanced protection across the entire UV-A and UV-B spectral range in cosmetic preparations. This is especially problematic when high sun protection performance is desired (for example, in preparations with an SPF of greater than or equal to 30). While the skilled person is familiar with a variety of UV-B filter substances, pure UV-A filters are rare. Furthermore, state-of-the-art UV-A filters have a number of specific disadvantages: • The filters (e.g. 2-(4'-diethylamino-2'-hydroxybenzoyl)-benzoic acid hexyl ester) colour the preparations strongly yellow in higher concentrations, which many consumers find unsightly. • The filters (e.g. phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts) glow under so-called "black light" as is known from discotheques and are therefore unsuitable for classic day care products (face creams). • The filters are photolabile (e.g.: 4-(tert.-butyl)-4'-methoxydibenzoylmethane) and decompose under the influence of UV light, which limits their durability and duration of use. • The filters (e.g.: 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt), phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts) are highly water-soluble due to their ionic structure (salts) and are washed off the body when bathing or sweating (unnoticed by the user).

[0006] UV-A filters therefore make the preparations visually unattractive and only effectively protect the human body from UV-A radiation for a limited period of time.

[0007] The object of the present invention was therefore to eliminate the deficiencies of the prior art. In particular, the object of the present invention was to develop a cosmetic preparation that is storage-stable, visually and sensorially appealing, and reliably protects the skin from UV-A radiation when used over a longer period of time. The preparations should be significantly more water- and sweat-resistant, especially with regard to UV-A protection.

[0008] Last but not least, the preparations should be simple and energy-efficient to produce.

[0009] Surprisingly, the tasks are solved by a cosmetic preparation containing a) 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt), b) 2,4,6-Tris-(biphenyl)-1,3,5-triazine.

[0010] Although the person skilled in the art is familiar with WO 2007 / 017179, this document could not point the way to the present invention.

[0011] The UV light protection filters according to the invention can, in the combination according to the invention, lead to superadditive UV light absorption (UV boost) and reduce the stickiness of, for example, sand on the skin.

[0012] According to the invention, the monosodium salt of 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt) is preferred. This salt has the following structure:

[0013] It is advantageous according to the invention if the preparation contains 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt) in a concentration of 0.1 to 10% by weight, based on the total weight of the preparation.

[0014] It is preferred according to the invention if the preparation contains 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation.

[0015] It is advantageous according to the invention if the preparation contains 2,4,6-tris-(biphenyl)-1,3,5-triazine in a concentration of 0.1 to 10% by weight, based on the total weight of the preparation.

[0016] It is preferred according to the invention if the preparation according to the invention contains 2,4,6-tris-(biphenyl)-1,3,5-triazine in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation.

[0017] Advantageous embodiments of the present invention are characterized in that the preparation contains one or more further UV filters selected from the group of the compounds phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidene camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(Dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-Methoxycinnamic acid (2-ethylhexyl) ester;4-Methoxyzimtsäureisoamylester; 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy-4'-methylbenzophenon; 2,2'-Dihydroxy-4methoxybenzophenon; 2-(4'-Diethylamino-2'-hydoxybenzoyl)-benzoesäurehexylester, 4-(tert.-Butyl)-4'-methoxydibenzoylmethan; Homomenthylsalicylat; 2-Ethylhexyl-2-hydroxybenzoat; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4''-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazin (INCI: Ethylhexyl Triazone); 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin (INCI: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazin);Titanium dioxide, zinc oxide, merocyanines selected from the group of compounds;

[0018] It is advantageous according to the invention if the preparation according to the invention contains one or more of these additional UV filters in a total concentration of 0.1 to 40% by weight and preferably in a concentration of 1 to 30% by weight, based on the total weight of the preparation.

[0019] It is advantageous according to the invention if the preparation according to the invention is free from p-methylbenzylidene camphor.

[0020] The pigments (titanium dioxide, zinc oxide) can advantageously also be used for the purposes of the present invention in the form of commercially available oily or aqueous predispersions. Dispersing aids and / or solubilizing agents can advantageously be added to these predispersions.

[0021] According to the invention, the pigments (titanium dioxide, zinc oxide) can advantageously be surface-treated ("coated"), for example, to create or maintain a hydrophilic, amphiphilic, or hydrophobic character. This surface treatment can consist of providing the pigments with a thin hydrophilic and / or hydrophobic inorganic and / or organic layer using conventional methods. The various surface coatings can also contain water within the meaning of the present invention.

[0022] Inorganic surface coatings in the sense of the present invention can consist of aluminum oxide (Al2O3), aluminum hydroxide Al(OH)3, or aluminum oxide hydrate (also: alumina, CAS No.: 1333-84-2), sodium hexametaphosphate (NaPO3)6, sodium metaphosphate (NaPO3) n, silicon dioxide (SiO2) (also: silica, CAS No.: 7631-86-9), barium sulfate (BaSO4), or iron oxide (Fe2O3). These inorganic surface coatings can occur alone, in combination, and / or in combination with organic coating materials.

[0023] Organic surface coatings within the meaning of the present invention can consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane units and silica gel), or alginic acid. These organic surface coatings can occur alone, in combination, and / or in combination with inorganic coating materials.

[0024] Advantageous embodiments of the present invention are characterized in that the preparation contains, as further ingredients, one or more compounds selected from the group of alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1,16-dicarboxylic acid, glyceryl glycose, (2-hydroxyethyl)urea, vitamin E or its derivatives and / or licochalcone A. Such active ingredients are advantageously present in a concentration of 0.01 to 10% by weight, and preferably in a concentration of 0.5 to 5% by weight, based on the total weight of the preparation.

[0025] It is advantageous in the sense of the present invention if the preparation contains one or more diols selected from the group of the compounds 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol.

[0026] According to the invention, such diols can advantageously be contained in the preparation in a concentration of 0.1 to 20% by weight, based on the total weight of the preparation.

[0027] According to the invention, such diols can preferably be contained in the preparation in a concentration of 0.5 to 10% by weight, based on the total weight of the preparation.

[0028] It is advantageous according to the invention if the preparation contains one or more parabens (e.g. methylparaben, ethylparaben, propylparaben, butylparaben).

[0029] A total paraben content of 0.05 to 1% by weight, based on the total weight of the preparation, is advantageous according to the invention.

[0030] According to the invention, it is advantageous if the preparation according to the invention is in the form of a gel, an emulsion, a dispersion, or an oil. Emulsions and dispersions are preferred according to the invention.

[0031] It is particularly preferred according to the invention if the preparation according to the invention is in the form of an O / W emulsion.

[0032] If the preparation according to the invention is in the form of an O / W emulsion, it is preferably characterized according to the invention in that the preparation contains one or more O / W emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3 methylglycose distearate, ceteareth-20, PEG-40 stearate, and sodium cetearyl sulfate. Furthermore, it is advantageous within the meaning of the present invention to use cetearyl alcohol in combination with PEG-40 hydrogenated castor oil, sodium cetearyl sulfate, and glyceryl stearate. Furthermore, it is advantageous according to the invention to use potassium cetyl phosphate as an emulsifier.

[0033] These O / W emulsifiers according to the invention can advantageously be contained in the preparation in a concentration of 0.001 to 10% by weight and preferably in a concentration of 0.1 to 7% by weight, based on the total weight of the preparation.

[0034] In a further embodiment of the invention, the preparation according to the invention is in the form of a W / O emulsion.

[0035] In this embodiment, it is preferred according to the invention if the preparation contains one or more W / O emulsifiers selected from the group of the compounds polyglyceryl-2 dipolyhydroxystearate, PEG-30 dipolyhydroxystearate, cetyl dimethicone copolyol, polyglyceryl-3 diisostearate.

[0036] These W / O emulsifiers according to the invention can advantageously be contained in the preparation in a concentration of 0.1 to 10% by weight and preferably in a concentration of 0.2 to 7% by weight, based on the total weight of the preparation.

[0037] It is advantageous in the sense of the present invention if the preparation contains one or more of the following compounds: methyl benzoate, limonene, citral, linalool, alpha-isomethyl ionone, geraniol, methyl 2-octynoate, citronellol, isoeugenol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, adipic acid diester, alpha-amyl cinnamaldehyde, alpha-methyl ionone, amyl cinnamyl butylphenyl methylpropional cinnamal, amyl salicylate, amyl cinnamyl alcohol, anise alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenyl methylpropional, Cardamom Oil, Cedrol, Cinnamal, Cinnamyl Alcohol, Citronellyl Methyl Crotonate, Citron Oil, Coumarin, Diethyl Succinate, d-Limonene, Ethyllinalool, Eugenol, Evernia Furfuracea Extract, Evernia Prunastri Extract, Farnesol, Guaiac Wood Oil, Hexyl Cinnamal, Hexyl Salicylate, Hydroxycitronellal,Hydroxyisohexyl 3-Cyclohexenecarboxaldehyde, Lavender Oil, Lemon Oil, Linalool Acetate, Mandarin Oil, Menthyl PCA, Methylheptenone, Nutmeg Oil, Rosemary Oil, Sweet Orange Oil, Terpineol, Tonka Bean Oil, Triethyl Citrate and / or Vanillin.

[0038] According to the invention, it is preferred if the total content of these compounds is from 0.001 to 0.5% by weight, based on the total weight of the preparations.

[0039] The preparations according to the invention may further advantageously also contain self-tanning substances, such as dihydroxyacetone and / or melanin derivatives in concentrations of 1% by weight up to 10% by weight, based on the total weight of the preparation.

[0040] Furthermore, the preparations according to the invention can advantageously also contain repellents for protection against mosquitoes, ticks, spiders, and the like. Examples of advantageous repellents are N,N-diethyl-3-methylbenzamide (trade name: Meta-delphene, "DEET"), dimethyl phthalate (trade name: Palatinol M, DMP), 1-piperidinecarboxylic acid 2-(2-hydroxyethyl)-1-methylpropyl ester, and especially 3-(Nn-butyl-N-acetylamino)-propionic acid ethyl ester (available from Merck under the trade name Insekt Repellent® 3535). The repellents can be used individually or in combination.

[0041] Moisturizers are substances or mixtures of substances which give cosmetic preparations the property of reducing the loss of moisture from the stratum corneum (also called transepidermal water loss (TEWL)) after application or distribution on the skin surface and / or of positively influencing the hydration of the stratum corneum.

[0042] Advantageous humectants (moisturizers) within the meaning of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccharide gum-1, glycine soya, ethylhexyloxyglycerin, pyrrolidonecarboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gellatable polysaccharides. Particularly advantageous are, for example, hyaluronic acid, chitosan and / or a fucose-rich polysaccharide, which is filed in Chemical Abstracts under the registration number 178463-23-5 and is available, for example, under the name Fucogel®1000 from SOLABIA SA. Moisturizers can also be advantageously used as anti-wrinkle active ingredients to protect against skin changes, such as those caused by, for example, acne. B. occur in skin aging.

[0043] It is advantageous in the sense of the present invention if the preparation according to the invention contains one or more humectants in a total concentration of 0.1 to 20% by weight and preferably in a total concentration of 0.5 to 10% by weight, in each case based on the total weight of the preparation.

[0044] The cosmetic preparations according to the invention may also advantageously, although not necessarily, contain fillers which, for example, further improve the sensory and cosmetic properties of the formulations and, for example, create or enhance a velvety or silky skin feel. Advantageous fillers within the meaning of the present invention are starch and starch derivatives (such as tapioca starch, distarch phosphate, aluminum or sodium starch octenylsuccinate, and the like), pigments which have neither a primarily UV-filtering nor coloring effect (such as boron nitride, etc.), and / or aerosils. ®(CAS No. 7631-86-9) and / or talc.

[0045] The aqueous phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol or polyols with a low carbon number and their ethers, preferably propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, polymers, foam stabilizers, electrolytes, self-tanning agents and, in particular, one or more thickeners, which can advantageously be selected from the group consisting of silicon dioxide, aluminum silicates, polysaccharides and their derivatives, e.g.Hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageous from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols, for example Carbopol types 980, 981, 1382, 2984, 5984, individually or in combination. Further thickeners advantageous according to the invention are those with the INCI name Acrylates / C10-30 Alkyl Acrylate Crosspolymer (e.g., Pemulen TR 1, Pemulen TR 2, Carbopol 1328 from NOVEON) and Aristoflex AVC (INCI: Ammonium Acryloyldimethyltaurate / VP Copolymer).

[0046] According to the invention, the preparation according to the invention advantageously contains film formers. Film formers within the meaning of the present invention are substances of various compositions that are characterized by the following property: If a film former is dissolved in water or other suitable solvents and the solution is then applied to the skin, it forms a film after the solvent evaporates, which essentially serves to fix the light filters to the skin and thus increase the water resistance of the product.

[0047] It is particularly advantageous to select film formers from the group of polymers based on polyvinylpyrrolidone (PVP). Particularly preferred are copolymers of polyvinylpyrrolidone, for example, PVP hexadecene copolymer and PVP eicosene copolymer, which are available from GAF Chemicals Cooperation under the trade names Antaron V216 and Antaron V220.

[0048] Other polymeric film formers are also advantageous, such as sodium polystyrene sulfonate, which is available under the trade name Flexan 130 from National Starch and Chemical Corp., and / or polyisobutene, available from Rewo under the trade name Rewopal PIB1000. Other suitable polymers include polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols, and acrylate / octylacrylamide copolymer (Dermacryl 79). Also advantageous is the use of hydrogenated castor oil dimer dilinoleate (CAS 646054-62-8, INCI Hydrogenated Castor Oil Dimer Dilinoleate), which can be purchased from Kokyu Alcohol Kogyo under the name Risocast DA-H, or PPG-3 benzyl ether myristate (CAS 403517-45-3), which can be purchased from Croda Chemicals under the trade name Crodamol STS.

[0049] The oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids with a chain length of 8 to 24, in particular 12 to 18, carbon atoms. The fatty acid triglycerides can advantageously be selected, for example, from the group of synthetic, semi-synthetic, and natural oils, such as cocoglyceride, olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil, and the like.

[0050] Also advantageous according to the invention are, for example, natural waxes of animal and plant origin, such as beeswax and other insect waxes as well as berry wax, shea butter and / or lanolin (wool wax).

[0051] Further advantageous polar oil components can be selected for the purposes of the present invention from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids with a chain length of 3 to 30 C atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms and from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms.Such ester oils can then advantageously be selected from the group of phenethyl benzoate, 2-phenylethyl benzoate, isopropyl lauroyl sarcosinate, phenyl trimethicone, cyclomethicone, dibutyl adipate, octyl palmitate, octyl cocoate, octyl isostearate, octyldodeceyl myristate, octyldodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl oleate, Erucyl erucate, tridecyl stearate, tridecyl trimellitate, as well as synthetic, semi-synthetic and natural mixtures of such esters, such as jojoba oil.

[0052] Furthermore, the oil phase can advantageously be selected from the group of dialkyl ethers and dialkyl carbonates; advantageous examples are dicaprylyl ether (Cetiol OE) and / or dicaprylyl carbonate, for example that available under the trade name Cetiol CC from Cognis.

[0053] It is further preferred to use the oil component(s) from the group consisting of isoeicosane, neopentyl glycol diheptanoate, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, C 12-13 -Alkyl lactate, di-C 12-13 -Alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tricaprylin, dimethyl isosorbide. It is particularly advantageous if the oil phase of the formulations according to the invention contains C 12-15 -alkyl benzoate or consists entirely of it.

[0054] Advantageous oil components also include, for example, butyloctyl salicylate (available under the trade name Hallbrite BHB from CP Hall), tridecyl salicylate (available under the trade name Cosmacol ESI from Sasol), C12-C15 alkyl salicylate (available under the trade name Dermol NS from Alzo), hexadecyl benzoate and butyloctyl benzoate and mixtures thereof (Hallstar AB) and / or diethylhexyl naphthalate (Hallbrite TQ or Corapan TQ from Symrise).

[0055] Any mixtures of such oil and wax components can also be used advantageously within the meaning of the present invention.

[0056] Furthermore, the oil phase can also advantageously contain non-polar oils, for example those selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petrolatum (petrolatum), liquid paraffin, squalane and squalene, polyolefins, hydrogenated polyisobutenes, C13-16 isoparaffin, and isohexadecane. Among the polyolefins, polydecenes are the preferred substances.

[0057] The preparations according to the invention may further advantageously contain one or more substances from the following group of siloxane elastomers, for example in order to increase the water resistance and / or the sun protection factor of the products: (a) Siloxane elastomers containing the units R2SiO and RSiO 1,5 and / or R3SiO 0,5 and / or SiO2, where the individual radicals R each independently represent hydrogen, C 1-24-Alkyl (such as methyl, ethyl, propyl) or aryl (such as phenyl or tolyl), alkenyl (such as vinyl) and the weight ratio of the units R2SiO to RSiO 1,5 selected from the range of 1 : 1 to 30 : 1; (b) siloxane elastomers which are insoluble and swellable in silicone oil and which are obtainable by the addition reaction of an organopolysiloxane (1) containing silicon-bonded hydrogen with an organopolysiloxane (2) containing unsaturated aliphatic groups, wherein the proportions used are chosen so that the amount of hydrogen of the organopolysiloxane (1) or of the unsaturated aliphatic groups of the organopolysiloxane (2) • is in the range of 1 to 20 mol% if the organopolysiloxane is not cyclic and • is in the range of 1 to 50 mol% if the organopolysiloxane is cyclic.

[0058] Advantageously within the meaning of the present invention, the siloxane elastomer(s) are in the form of spherical powders or in the form of gels.

[0059] Siloxane elastomers in the form of spherical powders which are advantageous according to the invention are those with the INCI name Dimethicone / Vinyl Dimethicone Crosspolymer, for example that available from DOW CORNING under the trade name DOW CORNING 9506 Powder.

[0060] It is particularly preferred if the siloxane elastomer is used in combination with oils from hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof.

[0061] Particularly advantageous preparations are also obtained when antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously contain one or more antioxidants. All antioxidants suitable or commonly used for cosmetic applications can be used as inexpensive, yet optional, antioxidants.

[0062] Water-soluble antioxidants, such as vitamins, e.g. ascorbic acid and its derivatives, can be used particularly advantageously within the meaning of the present invention.

[0063] Preferred antioxidants are also vitamin E and its derivatives as well as vitamin A and its derivatives.

[0064] The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30 wt.%, particularly preferably 0.05 to 20 wt.%, in particular 0.1 to 10 wt.%, based on the total weight of the preparation.

[0065] The cosmetic preparations according to the invention may contain cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, preservative aids, complexing agents, bactericides, perfumes, substances for preventing or increasing foaming, dyes, pigments having a coloring effect, thickeners, moisturizing and / or humectant substances, fillers that improve the feel of the skin, fats, oils, waxes or other customary components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

[0066] Preparations for skin care are advantageous within the meaning of the present invention: they can serve as cosmetic light protection and also as a make-up product in decorative cosmetics.

[0067] Depending on their structure, cosmetic compositions within the meaning of the present invention can be used, for example, as skin protection cream, day or night cream, etc. It is optionally possible and advantageous to use the compositions according to the invention as a basis for pharmaceutical formulations.

[0068] According to the invention, in particular, the use of the preparation according to the invention for protection against skin aging (in particular for protection against UV-induced skin aging) and as a sunscreen.

[0069] According to the invention, the preparation according to the invention advantageously has a pH value of 5 to 8. This can be adjusted using conventional acids, bases, and buffer systems.

[0070] According to the invention, the preparation is used in cosmetic sprays (in particular sunscreens).

[0071] According to the invention, the use is for impregnating cosmetic wipes. Examples

[0072] The following examples are intended to illustrate the present invention without limiting it. Unless otherwise stated, all quantities, proportions, and percentages are based on the weight and the total amount or the total weight of the preparations. emulsion 1 2 3 4 5 Glyceryl Stearate Citrate 2,5 2 3 Glyceryl Stearate SE 1 1 Cetearyl Alcohol + PEG-40 Castor Oil + Sodium Cetearyl Sulfate 2,5 2,5 Cetearyl alcohol 1 Stearyl alcohol 2 Cetyl alcohol 1 3 Acrylates / C 10-30 Alkyl Acrylat Crosspolymer 0,2 0,1 Carbomer 0,2 0,3 0,2 Xanthan Gum 0,4 0,2 0,2 0,3 C18-38 acid triglyceride 0,5 1 1 C 12-15 Alkyl Benzoat 3 5 C 12-13 Alkyl Tartrat 2 Myristyl myristate 2 1 Butylene glycol dicaprylate / dicaprate 3 3 Propylheptyl Caprylate 5 10 5 7 12 Dicaprylyl Ether 2 Octyldodecanol Cyclomethicon 2 5 1 Dimethicon 5 Isohexadecan 1 Butylene glycol 5 8 Propylene glycol 1 5 Glycerin 3 5 3 3 Octane-1,2-diol 2 5 2 2-Methyl-1,3-propanediol 2 5 4-Dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt) 2 1 3 0,5 4 Tris-(binphenyl)-1,3,5 triazine 2 2 3 2,5 2 Butyl Methoxydibenzoylmethan 1 Homosalat Phenylbenzimidazole sulfonic acid 2 Octyl salicylate 5 Octocrylen 2 Ethylhexyltriazine 3 Ethylhexylmethoxycinnamate 5 Dioctylbutylamidotriazin 2 PVP / hexadecene copolymer 0,2 0,5 0,1 0,2 Vitamin E acetate 0,2 0,2 0,2 0,3 0,1 Na2H2EDTA 0,1 0,1 0,2 0,2 0,2 perfume 0,2 0,3 0,3 0,4 0,25 Preservatives 0,3 0,5 1 0,4 0,6 Sodium hydroxide qs qs qs qs qs Water to 100.0 to 100.0 to 100.0 to 100.0 to 100.0 Example 6 7 8 9 10 Sodium stearoylglutamate 0,2 0,1 0,2 0,4 0,1 Sucrose polystearate 1 0,8 1 0,6 0,5 Cetearyl alcohol 1 Copolymer of vinylpyrrolidone and acrylic acid 0,3 0,4 0,7 Acrylate / Cl 0-30 Alkyl Acrylate Crosspolymer 0,3 0,2 0,2 Carbomer 0,2 C 12-15 Alkyl Benzoat 5 2 Butylenglycol Dicaprylat / Dicaprat 3 Octyldodekanol 3 Dicaprylylcarbonat 3 3 Caprylic / Capric Triglycerid 2 Isodecyl Neopentanoat 2 Cyclomethicon 5 3 Dimethicon 2 Glycerin 5 5 5 7 1 Hexan-1,2-diol 2 4 3 4-Dicyanomethylen-2,6-dimethyl-1,4-dihydropyridin-N-(ethyloxysulfatestersalz) 0,5 1 1,5 2 2,5 Tris-(binphenyl)-1,3,5 triazin 1 1 2 3 0,5 Ethylhexyltriazin 1 Butyl Methoxydibenzoylmethan 0,5 Diethylamino Hydroxybenzoyl Hexyl Benzoat 1 Polysilicon-15 2 Ethylhexyl Methoxycinnamat 5 Octylsalicylat 3 Homosalat 5 Octocrylen 5 Phenylbenzimidazol Sulfonsäure 2 Titandioxid 2 4 Ethanol 2 4 3 Parfüm, Konservierungsmittel Farbstoffe, Neutralisationsmittel etc q.s. q.s. q.s. q.s. q.s. Wasser ad 100,0 ad 100,0 ad 100,0 ad 100,0 ad 100,0 Emulsion 11 12 13 14 15 Glyceryl Stearat Citrat 2,5 2 Glyceryl Stearat SE 1 1 Cetearyl Alcohol + PEG-40 Rizinusöl+ Natrium Cetearyl Sulfat 2,5 2,5 PEG-30 Stearat 2 Cetearylalkohol 1 1 1 Stearylalkohol 2 1 Cetylalkohol 1 3 Acrylates / C 10-30 Alkyl Acrylat Crosspolymer 0,2 0,1 Carbomer 0,2 0,3 0,2 Xanthan Gum 0,4 0,2 0,2 0,3 C18-38 Säuretriglycerid 0,5 1 1 C 12-15 Alkyl Benzoat 3 2 5 C 12-13 Alkyl Tartrat 2 Myristylmyristat 1 2 1 Butylenglycol Dicaprylat / Dicaprat 3 3 Propylheptyl Caprylate 5 10 5 7 12 Dicaprylyl Ether 2 Octyldodecanol 1 2 Cyclomethicon 2 5 1 Dimethicon 5 Isohexadecan 1 Butylenglycol 5 2 Propylenglykol 1 5 Glycerin 3 5 3 3 Octan-1,2-diol 2 2 2 2-Methyl-1,3-propanediol 1 2 5 4-Dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt) 2 1 3 0,5 4 Tris-(binphenyl)-1,3,5 triazine 2 2 3 2,5 2 Butyl Methoxydibenzoylmethan 4 1 3 Homosalat 2 Phenylbenzimidazole sulfonic acid 2 Octyl salicylate 5 Octocrylen 6 2 5 8 Ethylhexyltriazine 3 Ethylhexylmethoxycinnamate 1 1 Dioctylbutylamidotriazin 1 1 2 PVP / hexadecene copolymer 0,2 0,5 0,1 0,2 Vitamin E acetate 0,2 0,2 0,2 0,3 0,1 Na2H2EDTA 0,1 0,1 0,2 0,2 0,2 perfume 0,2 0,3 0,3 0,4 0,25 Preservatives 0,3 0,5 1 0,4 0,6 Sodium hydroxide qs qs qs qs qs Water to 100.0 to 100.0 to 100.0 to 100.0 to 100.0

Claims

[1] Cosmetic preparation containing a) 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt), b) 2,4,6-Tris-(biphenyl)-1,3,5-triazine. [2] Cosmetic preparation according to claim 1, characterized by that the mono-sodium salt is used as the salt of 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt). [3] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N-(ethyloxysulfate ester salt) in a concentration of 0.1 to 10% by weight, based on the total weight of the preparation. [4] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains 2,4,6-tris-(biphenyl)-1,3,5-triazine in a concentration of 0.1 to 10% by weight, based on the total weight of the preparation. [5] Cosmetic preparation according to one of the preceding claims, characterized bythat the preparation contains one or more further UV filters selected from the group of the compounds phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidene camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(Dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-Methoxycinnamic acid (2-ethylhexyl) ester; 4-Methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone;2,2'-Dihydroxy-4-methoxybenzophenon; 2-(4'-Diethylamino-2'-hydoxybenzoyl)-benzoesäurehexylester, 4-(tert.-Butyl)-4'-methoxydibenzoylmethan; Homomenthylsalicylat; 2-Ethylhexyl-2-hydroxybenzoat; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; Dioctylbutylamidotriazon (INCl: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4''-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris-(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazin (INCl: Ethylhexyl Triazone); 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin (INCl: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazin); Titandioxid, Zinkoxid, Merocyanine gewählt aus der Gruppe der Verbindungen; [6] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains one or more diols selected from the group of the compounds 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol. [7] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains one or more parabens. [8] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation is in the form of an emulsion, in particular an O / W emulsion. [9] Cosmetic preparation according to one of the preceding claims, characterized bythat the preparation contains one or more O / W emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate, ceteareth-20, PEG-40 stearate, sodium cetearyl sulfate.